Status: current, Defined. Date: 30-Nov 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692981000168117 | Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3692991000168119 | Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has intended active ingredient | valsartan | true | Inferred relationship | Some | 365516744 | |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | Is a | Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) | true | Inferred relationship | Some | ||
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | Is a | amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has unit of use | tablet | true | Inferred relationship | Some | 365516745 | |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has Australian BoSS | valsartan | true | Inferred relationship | Some | 365516744 | |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has intended active ingredient | amlodipine | true | Inferred relationship | Some | 209280012 | |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 304352062 | |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has Australian BoSS | amlodipine | true | Inferred relationship | Some | 209280012 | |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 304352062 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet, 28 | has TPUU | True | Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | Inferred relationship | Some | 1 |
| Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet, 28, blister pack | has TPUU | True | Valsartan/Amlodipine/HCT 160/5/12.5 (Sandoz) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR